A long acting ophthalmic gel formulations of atenolol

Drug Development and Industrial Pharmacy

Volumn 33, Issue 11, 2007, Pages 1192-1198

  Hassan, Maha A ^a  

^a Assiut University   (Egypt)

Author keywords

Atenolol; Gel; Topical preparations

Indexed keywords

ALGINIC ACID; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBOXYMETHYLCELLULOSE; LONG ACTING DRUG; POLYMER;

ANIMAL EXPERIMENT; ARTICLE; CALCULATION; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION COEFFICIENT; DRUG EFFECT; DRUG FORMULATION; DRUG MECHANISM; DRUG PENETRATION; DRUG RELEASE; EXPERIMENTAL RABBIT; GEL; IN VITRO STUDY; INTRAOCULAR PRESSURE; MALE; NONHUMAN; TIME; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY;

ADRENERGIC BETA-ANTAGONISTS; ALGINATES; ANIMALS; ATENOLOL; CARBOXYMETHYLCELLULOSE; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; GELS; GLUCURONIC ACID; HEXURONIC ACIDS; INTRAOCULAR PRESSURE; MALE; OPHTHALMIC SOLUTIONS; RABBITS; SOLUBILITY; TIME FACTORS;

EID: 36749066708     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040701377433     Document Type: Article

References (15)

1. Albasini, M., & Ludwing, A. (1995). Evaluation of polysaccarides intended for ophthalmic uses in ocular dosage forms. Farmaco, 50, 633-642.
2. Babar, A., Solanki, U. D., Cutie, A. J., & Plakogiannis, F. (1990). Piroxicam release from dermatological bases: in vitro studies using cellulose membrane and hairless mouse skin. Drug Dev. Ind. Pharm., 16, 523-540.
3. Demou, J. S., Sidhon, M. B., & Plakogiannis, F. M. (1994). Comparative in vitro diffusion studies for atenolol transdermal delivery system. Pharm. Acta Helv., 68(4), 215-219.
4. Edsman, K., Carlfors, J., & Harju, K. (1996). Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use. Int. J. Pharm., 137, 233-241.
5. El-Gendy, A. M., Jun, H. W., & Kassem, A. A. (2002). In vitro release studies of flurbiprofen from different topical formulations. Drug Dev. Ind. Pharm., 28(7), 823-831.
6. El-Kamel, A. H. (2002). In vitro and in vivo evaluation of Pluronic F127-based ocular delivery system for timolol maleate. Int. J. Pharm., 241(1), 47-55.
7. Felt, O., Furrer, P., Mayer, J. M., Plazonnet, B., Buri, P., & Gurny, R. (1999). Topical use of chitosan in ophthalmology: Tolerance assessment and evaluation of precorneal retention. Int. J. Pharm., 180, 185-193.
8. Fitzgerated, P., & Wilson, C. (1994). Polymeric systems for ophthalmic drug delivery. In Severian, D. (Ed.), Polymeric systems for ophthalmic drug delivery (pp. 373-798). New York: Marcel Dekker.
9. Kaur, I. P., & Kanwar, M. (2002). Ocular preparations: The formulation approach. Drug Dev. Ind. Pharm., 28(5), 473-493.
10. Lin, H. R., & Sung, K.C. (2000). Carbopol/pluronic phase change solutions for ophthalmic delivery. J. Control Release, 69(3), 379-388.
11. Sechoy, O., Tissie, G., Sebastion, C., Maurin, F., Driot, J., & Trinquand, C. (2000). A new long acting ophthalmic formulation of carteolol containing alginic acid. Int. J. Pharm., 207, 109-116.
12. Thermes, F., Rozier, A., Plazonnet, B., & Grove, J. (1992). Bioadhesion: The effect of polyacrylic acid on the ocular bioavailability of timolol. Int. J. Pharm., 81, 59-65.
13. Tonnesen, H. H., & Karlsen, J. (2002). Alginate in drug delivery systems. Drug Dev. Ind. Pharm., 28(6), 621-630.
14. Xu, Y., & Chen, Z., Song, J. (2002). Effect of pilocarpine in new ophthalmic formulations on intraocular pressure in rabbits with ocular hypertension. Zhonghua Yan Ke Za Zhi, 38(12), 721-724.
15. Yie, T., Liang, L., & Chen, X. (2000). Clinical observation on the effect of 4% pilocarpine gel use one dose per day in the treatment of glaucoma. Yan Ke Xue Bao, 16(2), 77-80.